For patients who have undergone successful catheter ablation for atrial fibrillation, treatment with rivaroxaban does not ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback